Phommasone Koukeo, Chommanam Danoy, Christy Nathaniel C, Yiaye Touxiong, Phoutthavong Soulichanya, Keomoukda Patsalin, Thammavong Sompong, Bounphiengsy Thipsavanh, Lathsachack Thongsavanh, Boutthasavong Latsaniphone, Vidhamaly Vayouly, Sibounheuang Bountoy, Phonemixay Ooyanong, Panapruksachat Siribun, Praphasiri Viladeth, Keomany Sommay, Chaleunphon Bounthavy, Douangdala Phouvieng, Robinson Matthew T, Batty Elizabeth M, Vongsouvath Manivanh, Wiley Michael R, Wiley Jessica D, Chapman Ryan C, Letizia Andrew G, Mayxay Mayfong, Dubot-Pérès Audrey, Ashley Elizabeth A
Microbiology Laboratory, Lao-Oxford-Mahosot Hospital-Wellcome Trust Research Unit, Mahosot Hospital, Vientiane, Lao People's Democratic Republic
Microbiology Laboratory, Lao-Oxford-Mahosot Hospital-Wellcome Trust Research Unit, Mahosot Hospital, Vientiane, Lao People's Democratic Republic.
BMJ Open. 2025 Sep 4;15(9):e098006. doi: 10.1136/bmjopen-2024-098006.
Globally, the circulation of influenza and other seasonal respiratory viruses changed dramatically during the COVID-19 pandemic. This study aims to determine the trends of acute respiratory infections (ARIs) caused by SARS-CoV-2, influenza A, influenza B and respiratory syncytial viruses (RSVs) in patients presenting to hospitals in the Lao People's Democratic Republic (PDR) (Laos).
Prospective surveillance study.
Four provincial hospitals across Laos between March 2021 and July 2023.
Participants of all ages who met our case definition for an ARI (axillary temperature ≥37.5°C or history of fever AND cough or other respiratory symptoms/signs OR loss of smell and/or taste) presenting to the hospital less than 10 days after symptom onset were eligible to be enrolled in the study. Combined nasopharyngeal and throat swabs were tested for SARS-CoV-2, influenza A, influenza B and human RSV (hRSV) using probe-based real-time RT (Reverse transcription)-PCR assays.
The proportion of patients in whom SARS-CoV-2, influenza A, influenza B and hRSV was detected.
There were 4203 patients recruited, of whom 898 (21%) were children aged under 5 years. SARS-CoV-2 was detected in 16.9% of patients, followed by influenza A, influenza B and hRSV (8.4%, 7.2% and 4.7%, respectively). 98 patients (2.3%) were diagnosed with probable co-infection, with at least two viruses detected. After May 2022, the number of cases of influenza A, influenza B and hRSV increased rapidly. Six per cent of patients (263) had a quick Sequential Organ Failure Assessment score of ≥2, and 34 (0.8%) patients died, of whom 11 tested positive for a respiratory virus.
During the COVID-19 pandemic in Laos, few respiratory viruses were detected by passive surveillance until the relaxation of non-pharmaceutical interventions implemented for infection control. After restrictions were lifted, influenza A, influenza B and hRSV emerged rapidly, showing the importance of continuous surveillance.
在全球范围内,流感及其他季节性呼吸道病毒的传播在新冠疫情期间发生了巨大变化。本研究旨在确定在老挝人民民主共和国(老挝)医院就诊的患者中,由严重急性呼吸综合征冠状病毒2(SARS-CoV-2)、甲型流感病毒、乙型流感病毒和呼吸道合胞病毒(RSV)引起的急性呼吸道感染(ARI)的趋势。
前瞻性监测研究。
2021年3月至2023年7月期间老挝的四家省级医院。
所有符合我们ARI病例定义(腋温≥37.5°C或有发热史且伴有咳嗽或其他呼吸道症状/体征或嗅觉和/或味觉丧失)且在症状出现后不到10天到医院就诊的各年龄段参与者均有资格纳入本研究。使用基于探针的实时逆转录聚合酶链反应(RT-PCR)检测法对鼻咽和咽喉联合拭子进行SARS-CoV-2、甲型流感病毒、乙型流感病毒和人呼吸道合胞病毒(hRSV)检测。
检测出SARS-CoV-2、甲型流感病毒、乙型流感病毒和hRSV的患者比例。
共招募了4203名患者,其中898名(21%)为年龄在5岁以下的儿童。16.9%的患者检测出SARS-CoV-2,其次是甲型流感病毒、乙型流感病毒和hRSV(分别为8.4%、7.2%和4.7%)。98名患者(2.3%)被诊断为可能的合并感染,检测出至少两种病毒。2022年5月之后,甲型流感病毒、乙型流感病毒和hRSV的病例数迅速增加。6%的患者(263名)快速序贯器官衰竭评估评分≥2,34名(0.8%)患者死亡,其中11名呼吸道病毒检测呈阳性。
在老挝的新冠疫情期间,在为控制感染而实施的非药物干预措施放宽之前,通过被动监测检测到的呼吸道病毒很少。限制措施解除后,甲型流感病毒、乙型流感病毒和hRSV迅速出现,这表明持续监测的重要性。